Skip to main content
Fig. 5 | Journal of Experimental & Clinical Cancer Research

Fig. 5

From: Enhanced therapeutic effect of an antiangiogenesis peptide on lung cancer in vivo combined with salmonella VNP20009 carrying a Sox2 shRNA construct

Fig. 5

The quantification analysis of the IHC result. a The Sox2 positive cells per field were counted. The data shown was mean ± SD obtained from four fields. * P < 0.05 vs Mock group, ΔP = 0.055 vs HM-3 + shScr-V group. b The microvessel number per field was counted. The data shown was mean ± SD obtained from four fields. * P < 0.05 vs Mock group

Back to article page